| Remicade |
All Financial Data in US $ (mln) |
| Word Search (Top 10 - by date) |
Completes Post-Marketing Surveillance on All Patients With Refractory Uveoretinitis in Behcet's Disease REMICADE® I.V. Drip Infusion Anti-TNFA Monoclonal Antibody 100
Mitsubishi Tanabe Pharma
(August 18, 2010)
|
Merck Announces Second-Quarter 2010 Financial Results
Merck & Co
(July 30, 2010)
|
Summary of 1st Quarter Financial Results for year ended March 31, 2011
Mitsubishi Tanabe Pharma
(July 29, 2010)
|
Johnson & Johnson Reports 2010 Second-Quarter Results
Johnson & Johnson
(July 20, 2010)
|
GlaxoSmithKline and Mitsubishi Tanabe Pharma Corporation Terminates Co-promotion of Adoair®, the Combination Drug for Asthma and COPD
Mitsubishi Tanabe Pharma
(July 01, 2010)
|
CBio Announces Clinical Trial Milestone
CBio
(June 30, 2010)
|
Transition Therapeutics Announces Initiation of a Phase I Clinical Study of TT-301
Transition Therapeutics
(June 30, 2010)
|
Approval for Additional Indication of Ulcerative Colitis for Remicade® I.V. Drip Infusion 100, Anti-Human TNF a Monoclonal-Antibody
Mitsubishi Tanabe Pharma
(June 18, 2010)
|
POZEN Announces Election of Neal F. Fowler to the Board of Directors
POZEN
(June 15, 2010)
|
Summary of Financial Results for year ended March 31, 2010(Unaudited)
Mitsubishi Tanabe Pharma
(May 12, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
| Product Sales Summary 2007/08 |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2007 |
2008
|
2008 |
| Remicade2 |
|
|
|
4,433 |
5,302 |
|
+20% |
|
|
Note: Shaded Cells3 |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
|
|
|